Description

In vitro skin permeation study results comparing nanostructured versus conventional formulations of 5-alpha reductase inhibitors. Franz diffusion cell data demonstrate enhanced follicular targeting with nanocarriers.

Figure 7

Chart

Source Paper

Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to the Hair Follicle.

Pharmaceutics (2022)

PMID: 35214018

DOI: 10.3390/pharmaceutics14020286

Cite This Figure

![Figure 7: In vitro skin permeation study results comparing nanostructured versus conventional formulations of 5-alpha reductase inhibitors. Franz diffusion cell data demonstrate enhanced follicular targeting with nanocarriers.]()

> Source: Silvia Tampucci et al. "Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to t." *Pharmaceutics*, 2022. PMID: [35214018](https://pubmed.ncbi.nlm.nih.gov/35214018/)

<figure>
  <img src="" alt="In vitro skin permeation study results comparing nanostructured versus conventional formulations of 5-alpha reductase inhibitors. Franz diffusion cell data demonstrate enhanced follicular targeting with nanocarriers." />
  <figcaption>Figure 7. In vitro skin permeation study results comparing nanostructured versus conventional formulations of 5-alpha reductase inhibitors. Franz diffusion cell data demonstrate enhanced follicular targeting with nanocarriers.<br>  Source: Silvia Tampucci et al. "Nanostructured Drug Delivery Systems for Targeting 5-α-Reductase Inhibitors to t." <em>Pharmaceutics</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35214018/">35214018</a></figcaption>
</figure>

Preuves associées

Minoxidil pour Alopécie Androgénétique

Note A · 299 études

Finasteride pour Alopécie Androgénétique

Note A · 206 études

Dutasteride pour Alopécie Androgénétique

Note A · 99 études